Journal article
Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.
Abstract
OBJECTIVE: To determine whether recombinant human erythropoietin improves the quality of life and exercise capacity of anaemic patients receiving haemodialysis.
DESIGN: A double blind, randomised, placebo controlled study.
Journal
The BMJ, Vol. 300, No. 6724,
Publisher
BMJ
Publication Date
March 3, 1990
DOI
10.1136/bmj.300.6724.573
ISSN
0959-8138